Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
01/2006
01/05/2006US20060004062 Compounds for inhibiting insulin secretion and methods related thereto
01/05/2006US20060004048 Novel biaromatic compounds which activate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof
01/05/2006CA2570499A1 Method for producing 4-(benzimidazolylmethylamino)-benzamidines
01/04/2006EP0934288B1 Oxadiazoles, processes for their preparation and their use as medicaments
12/2005
12/29/2005WO2005074604A3 METHODS OF DETECTING Lp-PLA2 ACTIVITY
12/29/2005US20050288336 Cysteine protease inhibitors
12/29/2005US20050288282 Anticancer agents; antiproliferative agents
12/29/2005US20050288186 1-(4-{3-[2,6-Dichloro-4-(3,3-dichloro-allyloxy)-phenoxy]-propoxy}-phenyl)-1H-pyrrole, for example; protecting soybean plants against pests such as caterpillars
12/28/2005EP1609784A1 Process for the preparation of 4-(benzimidazolylmethylamino)-benzamidines
12/28/2005EP1608633A1 Non-nucleoside reverse transcriptase inhibitors i for treating hiv mediated diseases
12/28/2005EP1608616A1 Biphenyl carboxylic amide p38 kinase inhibitors
12/28/2005CN1714079A Mandelic acid derivatives
12/28/2005CN1714076A Novel aryl ureido benzoic acid derivatives and their use
12/28/2005CN1714070A Vitamin d receptor modulators
12/27/2005CA2256332C Substituted sulphonyl amino(thio)carbonyl compounds and their use as herbicides
12/22/2005WO2005120515A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
12/22/2005US20050282818 Ubiquitin ligase inhibitors
12/22/2005CA2567835A1 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
12/21/2005EP1607392A1 Blue light-emitting compound, method for producing same and light-emitting device utilizing same
12/21/2005EP1265859B1 Amidino compounds useful as nitric oxide synthase inhibitors
12/21/2005CN1711239A Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
12/21/2005CN1232505C Substituted sulfamide (thio) carbonyl compounds
12/21/2005CN1232503C Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same
12/20/2005US6977256 Compounds and compositions as cathepsin S inhibitors
12/15/2005WO2004078734A8 TETRAZOLE AND OXADIAZOLONE SUBSTITUTED β-AMINO ACID DERIVATIVES
12/14/2005EP1603890A1 TETRAZOLE AND OXADIAZOLONE SUBSTITUTED &bgr;-AMINO ACID DERIVATIVES
12/14/2005EP1603858A2 Kcnq channel modulating compounds and their pharmaceutical use
12/14/2005EP1440052B1 Benzamide derivatives as antagonists of orexin receptors
12/14/2005CN1706835A Prepn process of 5-alkyl-1,3,4-oxidazole ketone
12/08/2005WO2005115995A1 Amine compound and organic electroluminescent element employing the same
12/08/2005US20050272718 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
12/07/2005EP1601354A2 Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
12/07/2005CN1230418C Selective androgen receptor modulators and methods of use thereof
12/01/2005WO2005113490A1 Sulfone-containing prodrugs
12/01/2005US20050267152 Gly1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
12/01/2005US20050267044 Novel compounds and compositions as cathepsin S inhibitors
12/01/2005US20050267032 Sulfone-containing prodrugs
11/2005
11/30/2005EP1600442A1 Heteroarylcarbamoylbenzene derivative
11/30/2005EP1156787B1 Oxadiazole compounds and compositions for delivering active agents
11/30/2005EP1091943B1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
11/30/2005CN1703407A Inhibitors of fatty acid amide hydrolase
11/30/2005CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation
11/30/2005CN1229377C Spiro [Piperidine-4,1'-pyrrolo[3,4-c] pyrrole]
11/29/2005US6969727 Obesity; osteoporosis
11/24/2005WO2004091502A8 1,2,4-oxadiazole benzoic acid compounds
11/24/2005US20050261318 Protein kinase inhibitors
11/24/2005US20050261291 1-Cyclopropylmethyl-4-[2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine or a salt or hydrate; exhibit excellent cell adhesion inhibitory action or cell infiltration inhibitory action; for treating inflammatory diseases and autoimmune diseases such as inflammatory bowel diseases and rheumatoid arthritis
11/23/2005EP1598067A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
11/23/2005EP1597248A2 Sulfonamide derivatives as ppar modulators
11/23/2005EP1597243A1 Heterocyclic compounds useful as nurr-1 activators
11/23/2005EP1335898B1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
11/23/2005CN1228337C Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
11/17/2005WO2005108382A1 1,2,4-oxadiazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
11/17/2005WO2005108370A1 Benzene compounds
11/17/2005WO2005107762A2 Certain chemical entities, compositions, and methods
11/17/2005US20050256199 2-Amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
11/17/2005US20050256116 Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
11/17/2005CA2565695A1 Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder
11/17/2005CA2564264A1 1,2,4-oxadiazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
11/16/2005CN1227244C Herbicidal benzoyl derivatives
11/15/2005US6964983 Compounds that modulate PPAR activity and methods for their preparation
11/10/2005WO2005032465A3 3,5-aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists
11/10/2005US20050250959 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/09/2005EP1593671A1 DPP-IV inhibitors
11/09/2005EP1501787B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
11/09/2005EP1216223B1 Novel dicarboxylic acid derivatives with pharmaceutical properties
11/09/2005EP1212296B1 Phosphate mimics and methods of treatment using phosphatase inhibitors
11/08/2005CA2155104C Heterocyclic-substituted alkyl amide acat inhibitors
11/03/2005WO2005103020A1 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
11/03/2005WO2005086871A9 Compounds, compositions and methods for inhibiting or treating hiv-1
11/03/2005WO2004099165A3 Heterocyclic compounds and hydro isomers thereof
11/03/2005US20050245542 Pyridazine, pyrimidine and pyrazine ethyne compounds
11/03/2005CA2563615A1 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
11/02/2005EP1590340A1 Inhibitors of histone deacetylase
11/02/2005EP1590323A2 Piperazine derivatives and their use as synthesis intermediates
11/02/2005EP1383749B1 Arylsulfonamides as antiviral agents
11/02/2005CN1692109A Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
11/02/2005CN1691944A Oxadiazoles as modulators of metabotropic glutamate receptor-5
11/02/2005CN1225471C Compounds with growth hormone releasing properties
11/01/2005US6960688 Use of compounds for the elevation of pyruvate dehydrogenase activity
11/01/2005US6960604 Thyroid receptor ligands
10/2005
10/27/2005WO2005100298A1 Cetp inhibitors
10/27/2005US20050240023 Cathepsin cysteine protease inhibitors
10/27/2005US20050235428 Use of metal complex compounds as oxidation catalysts
10/27/2005DE102004016845A1 Phenylthioessigsäure-Derivate und ihre Verwendung Phenylthioacetic acid derivatives and their use
10/27/2005CA2562082A1 Cetp inhibitors for the treatment and prevention of atherosclerosis
10/26/2005CN1224598C Naphthalene derivatives
10/25/2005US6958352 Compounds for inhibiting insulin secretion and methods related thereto
10/25/2005CA2304974C 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
10/25/2005CA2147056C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
10/20/2005WO2005097784A1 Phenylthioacetic acid derivatives and use thereof
10/20/2005US20050234125 Alpha-sulfonylamino-acetonitriles
10/20/2005US20050234111 D-homo-17-chlor-16(17)-ene steroids
10/20/2005US20050234106 1-aryl-1-heteroarylaminoalkylene-substituted, e.g., 1-[fluorophenylcyclohexylmethyl]isoquinolin-1-ylamine; antiarrhythmia agents; cardiovascular disorders
10/20/2005CA2562140A1 Phenylthioacetic acid derivatives and use thereof
10/19/2005EP1585518A2 Peptide deformylase inhibitors
10/19/2005CN1684944A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/13/2005WO2005095343A1 Dpp-iv inhibitors
10/13/2005WO2005095334A1 Sulfonamide compounds for the treatment of neurodegenerative disorders
10/13/2005US20050228015 Substituted heteroaryl- and phenylsulfamoyl compounds
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 72